寨卡病毒与血液安全

doi:10.3969/j.issn.1671-2587.2024.06.024

临床输血与检验 ›› 2024, Vol. 26 ›› Issue (6): 859-864.DOI: 10.3969/j.issn.1671-2587.2024.06.024

• 综述 • 上一篇

寨卡病毒与血液安全

王义来, 陈庆恺, 韩国伟, 何子毅

东莞市中心血站,广东东莞 523000

收稿日期:2024-01-30 出版日期:2024-12-20 发布日期:2024-12-20
通讯作者: 韩国伟,主要从事血液安全研究,（E-mail）13642849111@139.com。何子毅,主要负责血液安全检测和血型血清学研究,（E-mail）zyhe_8@163.com。
作者简介:王义来,主要从事输血医学研究,（E-mail）1448086427@qq.com。

Zika Virus and Blood Safety

WANG Yilai, CHEN Qingkai, HAN Guowei, HE Ziyi

Dongguan Blood Center, Dongguan 523000

Received:2024-01-30 Online:2024-12-20 Published:2024-12-20

摘要/Abstract

摘要： 近年来寨卡病毒（zika virus, ZIKV）在全球多地暴发流行,在我国也有呈局部流行的趋势,不仅严重威胁公共卫生,也对血液安全造成了威胁。本文将ZIKV国内外流行现状、传播途径、实验室检查、输血传播的潜在风险及防控输血传播策略综述如下。

关键词: 寨卡病毒, 血液安全, 蚊媒传播, 无症状感染, 病原体灭活/减少技术

Abstract: In recent years, the Zika virus has broken out in many places around the world, and there is also a trend of local epidemic in China, which not only poses a serious threat to public health, but also to blood safety. The paper summarises the current status of ZIKV prevalence at home and abroad, routes of transmission, laboratory tests, potential risks of transmission through blood transfusion and strategies for transfusion transmission prevention.

Key words: Zika virus, Blood safety, Mosquito-borne transmission, Asymptomatic infection, Pathogen reduction technology

中图分类号:

R373

王义来, 陈庆恺, 韩国伟, 何子毅. 寨卡病毒与血液安全[J]. 临床输血与检验, 2024, 26(6): 859-864.

WANG Yilai, CHEN Qingkai, HAN Guowei, HE Ziyi. Zika Virus and Blood Safety[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 859-864.

参考文献

[1] POSTLER T S,BEER M,BLITVICH B J,et al.Renaming of the genus Flavivirus to Orthoflavivirus and extension of binomial species names within the family Flaviviridae[J].Arch Virol,2023,168(9):224.
[2] HADDOW A D,SCHUH A J,YASUDA C Y,et al.Genetic characterization of Zika virus strains:geographic expansion of the Asian lineage[J].PLoS Negl Trop Dis,2012,6(2):e1477.
[3] BERNARDO-MENEZES L C,AGRELLI A,OLIVEIRA A S L E,et al.An overview of Zika virus genotypes and their infectivity[J].Rev Soc Bras Med Trop,2022,55:e02632022.
[4] DE MELO FREIRE C C,IAMARINO A,DE LIMA NETO D F,et al.Spread of the pandemic Zika virus lineage is associated with NS1 codon usage adaptation in humans[C].2015
[5] ATIF M,AZEEM M,SARWAR M R,et al.Zika virus disease:a current review of the literature[J].Infection,2016,44(6):695-705.
[6] GOURINAT A C,O'CONNOR O,CALVEZ E,et al. Detection of Zika virus in urine[J].Emerg Infect Dis,2015,21(1):84-86.
[7] OEHLER E,WATRIN L,LARRE P,et al.Zika virus infection complicated by Guillain-Barre syndrome—case report,French Polynesia,December 2013[J].Euro Surveill,2014,19(9):20720.
[8] BAUD D,GUBLER D J,SCHAUB B,et al.An update on Zika virus infection[J].Lancet,2017,390(10107):2099-2109.
[9] WHO.Zika Virus (ZIKV) classification table[EB/OL].[2024-1-21].http://apps.who.int/iris/bitstream/handle/10665/260419/zika-classification-15Feb18-eng.pdf?sequeence=1,2018-02-15.
[10] 李建华,黄仁发,杨健平,等.中国大陆首例输入性寨卡病毒感染病例临床表现及实验室检测结果分析[J].中国公共卫生,2016,32(4):413-415.
[11] HSIEH C J,WU W T,LIN M H,et al.Epidemiological characteristics of zika virus infections imported into Taiwan between 2016 and 2021[J].J Med Sci,2024.
[12] 王亚丽,张晓怡,任瑞琦,等.中国内地25例输入性寨卡病毒病病例流行病学与临床特征分析[J].中国媒介生物学及控制杂志,2017,28(6):535-537.
[13] 李多,曹继东,康家荣,等.云南省首例输入性寨卡病毒病病例流行病学调查及病原分子特征分析[J].中国病毒病杂志,2022,12(5):358-363.
[14] WEAVER S C,CHARLIER C,VASILAKIS N,et al.Zika,chikungunya,and other emerging vector-borne viral diseases[J].Annu Rev Med,2018,69:395-408.
[15] COUNOTTE M J,KIM C R,WANG J Y,et al.Sexual transmission of Zika virus and other flaviviruses:a living systematic review[J].PLoS Med,2018,15(7):e1002611.
[16] SPITERI G,SUDRE B,SEPTFONS A,et al.Surveillance of Zika virus infection in the EU/EEA,June 2015 to January 2017[J].Euro Surveill,2017,22(41): 17-00254.
[17] Prevention C F D C.Zika cases in the United States: cumulative Zika virus disease case counts in the United States,2015-2018[EB/OL].[2024-1-21].https://www.cdc.gov/zika/reporting/case-counts.html.
[18] BESNARD M,LASTèRE S,TEISSIER A,et al.Evidence of perinatal transmission of Zika virus,French Polynesia,December 2013 and February 2014[J].Euro Surveill,2014,19(13):20751.
[19] ODUYEBO T,PETERSEN E E,RASMUSSEN S A,et al.Update:interim guidelines for health care providers caring for pregnant women and women of reproductive age with possible zika virus exposure-United States,2016[J].MMWR Morb Mortal Wkly Rep,2016,65(5):122-127.
[20] LIU R F,WANG X Z,MA Y,et al.Prevalence of Zika virus in blood donations:a systematic review and meta-analysis[J].BMC Infect Dis,2019,19(1):590.
[21] MOTTA I J F,SPENCER B R,CORDEIRO DA SILVA S G,et al.Evidence for transmission of zika virus by platelet transfusion[J].N Engl J Med,2016,375(11):1101-1103.
[22] 慕容容,叶海艳,徐敏,等.寨卡病毒感染与输血安全[J].中国输血杂志,2021,34(4):424-427.
[23] KHONGWICHIT S,CHUCHAONA W,VONGPUNSAWAD S,et al.Molecular epidemiology,clinical analysis,and genetic characterization of Zika virus infections in Thailand (2020-2023)[J].Sci Rep,2023,13(1):21030.
[24] NOORBAKHSH F,ABDOLMOHAMMADI K,FATAHI Y,et al.Zika virus infection,basic and clinical aspects:a review article[J].Iran J Public Health,2019,48(1):20-31.
[25] WANG Z Y,WANG P G,AN J.Zika virus and Zika fever[J].Virol Sin,2016,31(2):103-109.
[26] MASMEJAN S,MUSSO D,VOUGA M,et al.Zika virus[J].Pathogens,2020,9(11):898.
[27] 贺梦娇,秦成峰,李晓峰.先天性寨卡综合征及其致病机制研究进展[J].科学通报,2021,66(31):3937-3943.
[28] 常嘉彤,盛子洋,王培刚.先天性非小头畸形寨卡病毒感染的研究进展[J].微生物学免疫学进展,2021,49(5):78-83.
[29] FILGUEIRAS I S,TORRENTES DE CARVALHO A,CUNHA D P,et al.The clinical spectrum and immunopathological mechanisms underlying ZIKV-induced neurological manifestations[J].PLoS Negl Trop Dis,2021,15(8):e0009575.
[30] HE Z J,AN S,CHEN J H,et al.Neural progenitor cell pyroptosis contributes to Zika virus-induced brain atrophy and represents a therapeutic target[J].Proc Natl Acad Sci USA,2020,117(38):23869-23878.
[31] ADAM A,LEE C,WANG T.Rational development of live-attenuated zika virus vaccines[J].Pathogens,2023,12(2):194.
[32] LOW S L,LEO Y S,LAI Y L,et al.Evaluation of eight commercial Zika virus IgM and IgG serology assays for diagnostics and research[J].PLoS One,2021,16(1):e0244601.
[33] HAYES E B.Zika virus outside Africa[J].Emerg Infect Dis,2009,15(9):1347-1350.
[34] CHAN K R,ISMAIL A A,THERGARAJAN G,et al.Serological cross-reactivity among common flaviviruses[J].Front Cell Infect Microbiol,2022,12:975398.
[35] STONE M,BAKKOUR S,LANTERI M C,et al.Zika virus RNA and IgM persistence in blood compartments and body fluids:a prospective observational study[J].Lancet Infect Dis,2020,20(12):1446-1456.
[36] 李阿茜,梁米芳,李建东,等.用于检测登革热,基孔肯雅及寨卡病毒的三重实时荧光定量PCR引物和探针及试剂盒[P].2022.
[37] 滕新栋,刘迪,杨宇,等.一种基于RAA技术的白纹伊蚊及携带寨卡病毒,基孔肯雅病毒和登革病毒同时检测试剂盒及检测方法[P].2023.
[38] LUM F M,LIN C,SUSOVA O Y,et al.A sensitive method for detecting zika virus antigen in patients' whole-blood specimens as an alternative diagnostic approach[J].J Infect Dis,2017,216(2):182-190.
[39] IOOS S,MALLET H P,LEPARC GOFFART I,et al.Current Zika virus epidemiology and recent epidemics[J].Med Mal Infect,2014,44(7):302-307.
[40] GIMéNEZ-RICHARTE á,ORTIZ DE SALAZAR M I,GIMéNEZ-RICHARTE M P,et al.Transfusion-transmitted arboviruses:update and systematic review[J].PLoS Negl Trop Dis,2022,16(10):e0010843.
[41] FAYE O,FAYE O,DIALLO D,et al.Quantitative real-time PCR detection of Zika virus and evaluation with field-caught mosquitoes[J].Virol J,2013,10:311.
[42] DUFFY M R,CHEN T H,HANCOCK W T,et al.Zika virus outbreak on Yap Island,Federated States of Micronesia[J].N Engl J Med,2009,360(24):2536-2543.
[43] PLOURDE A R,BLOCH E M.A literature review of zika virus[J].Emerg Infect Dis,2016,22(7):1185-1192.
[44] STONE M,LANTERI M C,BAKKOUR S,et al.Relative analytical sensitivity of donor nucleic acid amplification technology screening and diagnostic real-time polymerase chain reaction assays for detection of Zika virus RNA[J].Transfusion,2017,57(3pt2):734-747.
[45] SLAVOV S N,HESPANHOL M R,RODRIGUES E S,et al.Zika virus RNA detection in asymptomatic blood donors during an outbreak in the northeast region of So Paulo State,Brazil,2016[J].Transfusion,2017,57(12):2897-2901.
[46] GALLIAN P,CABIé A,RICHARD P,et al.Zika virus in asymptomatic blood donors in Martinique[J].Blood,2017,129(2):263-266.
[47] ZHENG X,ZENG J F,XU X X,et al.A preliminary survey of Zika virus infection by nucleic acid test in the volunteer blood donor samples in Shenzhen China[J].J Med Virol,2020,92(8):1326-1329.
[48] ZHOU C M,LIU J W,QI R,et al.Emergence of Zika virus infection in China[J].PLoS Negl Trop Dis,2020,14(5):e0008300.
[49] BENJAMIN R J.Zika virus in the blood supply[J].Blood,2017,129(2):144-145.
[50] 郭永建. 美国FDA《血液行业指引:降低寨卡病毒输血传播风险的推荐意见》主要内容及其启示[J].中国输血杂志,2016,29(2):227-230.
[51] PETERSEN L R,JAMIESON D J,POWERS A M,et al.Zika virus[J].N Engl J Med,2016,374(16):1552-1563.
[52] CHEVALIER M S,BIGGERSTAFF B J,BASAVARAJU S V,et al.Use of blood donor screening data to estimate zika virus incidence,Puerto Rico,april-august 2016[J].Emerg Infect Dis,2017,23(5):790-795.
[53] SAá P,PROCTOR M,FOSTER G,et al.Investigational testing for zika virus among U.S.blood donors[J].N Engl J Med,2018,378(19):1778-1788.
[54] GOODNOUGH L T,MARQUES M B.Zika virus and patient blood management[J].Anesth Analg,2017,124(1):282-289.
[55] LESSLER J,OTT C T,CARCELEN A C,et al.Times to key events in Zika virus infection and implications for blood donation:a systematic review[J].Bull World Health Organ,2016,94(11):841-849.
[56] FRYK J J,MARKS D C,HOBSON-PETERS J,et al.Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light[J].Transfusion,2017,57(11):2677-2682.
[57] WANG Y C,REN K,LIAO X Z,et al.Inactivation of Zika virus in plasma and derivatives by four different methods[J].J Med Virol,2019,91(12):2059-2065.
[58] LAUGHHUNN A,SANTA MARIA F,BROULT J,et al.Amustaline (S-303) treatment inactivates high levels of Zika virus in red blood cell components[J].Transfusion,2017,57(3pt2):779-789.
[59] GIMéNEZ-RICHARTE á,ORTIZ DE SALAZAR M I,GIMéNEZ-RICHARTE M P,et al.Pathogen inactivation methods to prevent transfusion-transmissible arboviruses:a systematic review and meta-analysis[J].Trop Med Int Health,2023,28(4):262-274.

寨卡病毒与血液安全

Zika Virus and Blood Safety

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	杨剑豪, 邱颖婕, 章舜玮, 杜祎, 胡天彦, 徐蓓. 上海地区单采血小板阳性细菌筛查结果评估[J]. 临床输血与检验, 2024, 26(4): 499-504.
[2]	刘鸿, 莫琴, 马荣钠, 贾尧, 伍晓菲, 王迅. 不同核黄素浓度与可见光光照强度对血浆中大肠杆菌的影响^*[J]. 临床输血与检验, 2024, 26(1): 29-34.
[3]	郭天虹, 王雨涵, Claudia SC, 黄远帅. 基于研究证据的输血医学新进展[J]. 临床输血与检验, 2023, 25(4): 572-576.
[4]	赵冬雁, 沈有华, 田志彬, 项征国, 李涛, 张微, 张国权, 李玲, 徐今晶, 薛双林, 张丹, 王晓颖, 袁晓华, 侯玲华, 马立仙, 段志倩, 李丽, 贾红志, 赵兰青, 王振兴, 范丽莉, 张珩, 张秀琪, 程念念, 赵超, 邱艳. 全血献血人群和单采献血人群延迟献血因素的对比分析研究[J]. 临床输血与检验, 2023, 25(3): 388-395.
[5]	黄霞, 杨俊鸿, 何涛. 血液安全监测选择与未来^*[J]. 临床输血与检验, 2023, 25(1): 10-15.
[6]	谢东甫, 黄霞, 杨俊鸿, 孙洁, 张晰, 何涛. 国内外血液安全监测报告若干数据指标的比较与分析^*[J]. 临床输血与检验, 2023, 25(1): 16-20.
[7]	杨俊鸿, 胡文杰, 杨培, 邓莉, 黄霞, 徐永柱. 某血液中心开展献血不良反应监测实践及效果评价^*[J]. 临床输血与检验, 2023, 25(1): 21-25.
[8]	朱文钦, 陈齐, 曾嘉, 黄霞. 福州地区全血献血不良反应哨点监测情况分析[J]. 临床输血与检验, 2023, 25(1): 26-32.
[9]	王胜蓝, 贵明飞, 华敏玉, 李鹏, 卓创近, 刘钟梅, 杨霞, 黄霞, 何涛. 急性输血不良反应发生时间调查及分析^*[J]. 临床输血与检验, 2023, 25(1): 33-37.
[10]	程志祥, 任林, 曹红荣, 张玉, 王珊珊, 张国庆, 黄霞. 基于《血液安全监测指南》开展临床输血不良事件监测的探索^*[J]. 临床输血与检验, 2023, 25(1): 48-55.
[11]	代华友, 刘开强, 刘晓杰, 华敏玉, 黄梅, 邱晓珊, 李莉华, 黄霞. 2020~2021年全国部分地区采供血不良事件哨点监测情况分析^*[J]. 临床输血与检验, 2023, 25(1): 56-62.
[12]	陈敏, 杨俊鸿. 血小板细菌污染控制与监测研究进展^*[J]. 临床输血与检验, 2021, 23(6): 811-816.
[13]	杨俊鸿, 许茜, 黄霞, 何涛. 英美两国献血者安全监测体系比较与启示^*[J]. 临床输血与检验, 2021, 23(5): 671-676.
[14]	刘奇, 王世春, 姚春艳. 伽马射线辐照对血小板贮存损伤的影响^*[J]. 临床输血与检验, 2021, 23(4): 535-540.
[15]	朱永明. 血液工作的总目标与当前的一些主要问题[J]. 临床输血与检验, 2021, 23(1): 6-10.